Feature

New Novartis Biomedical Research Facility Planned for San Diego

Part of a broader multibillion-dollar effort to expand R&D and manufacturing in the US

  • By

  • February 16, 2026

  • 3 min

Share

Novartis is constructing a new 466,000-square-foot Biomedical Research center in San Diego, expected to be operational in 2029. This facility will house around 1,000 employees and enhance Novartis' drug discovery capabilities, integrating with research sites in Cambridge and Basel. Focused on neuroscience and oncology, it aims to accelerate innovation in drug development, leveraging advanced technologies like gene and cell therapies, while reinforcing collaborations within the biotech ecosystem. This initiative is part of a USD 23 billion US investment plan.

Original Source(s)

New Novartis Biomedical Research Facility Planned for San Diego

Part of a broader multibillion-dollar effort to expand R&D and manufacturing in the US

  • February 16, 2026

  • 3 min

Related Content

Breaking the Biomarker Bottlenecks: Part 2

Industry leaders from AstraZeneca, Leica Biosystems, and Danaher share their insights on AI’s power to democratize access to precision medicine

  • February 16, 2026

  • 9 min
Roswell Park Achieves National Accreditation for Rectal Cancer Care

Team recognized by National Accreditation Program for Rectal Cancer and American College of Surgeons.

  • February 13, 2026

Breaking the Biomarker Bottlenecks: Part 1

When pharmaceutical and diagnostic companies collaborate, precision medicine reaches patients faster, say these industry leaders

  • February 13, 2026

  • 12 min